RNAC - Cartesian Therapeutics, Inc.
9.9
-0.520 -5.253%
Share volume: 215,900
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$10.42
-0.52
-0.05%
Summary score
47%
Profitability
68%
Dept financing
25%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
17.87%
Return on assets
-3.5%
Return on sales
-280.24%
Return on invested capital
25.71%
Total debt ratio
85.95%
Debt ratio change over timeo
-2.52%
Current Ratio
5.13%
Quick Ratio
3.74%
Cash Position Ratio
4.69%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-2.34%
Return on sales
524.36%
Return on invested capital
0%
Total debt ratio
112.02%
Debt ratio change over timeo
-5.03%
Current Ratio
8.85%
Quick Ratio
0%
Cash Position Ratio
8.21%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.82%
Return on sales
-1989.91%
Return on invested capital
0%
Total debt ratio
105.33%
Debt ratio change over time
0%
Current Ratio
12.34%
Quick Ratio
0%
Cash Position Ratio
12.03%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-250.53%
Return on assets
-102.25%
Return on sales
-108.18%
Return on invested capital
-121.77%
Total debt ratio
-251.77%
Debt ratio change over time
-2.52%
Current Ratio
-5.44%
Quick Ratio
-4.56%
Cash Position Ratio
-4.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNAC | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 17.87% | 14.28% | 9.23% | 0% |
| Return on assets | -3.5% | 4.23% | 3.2% | 0% |
| Return on sales | -280.24% | 27.89% | 25.03% | 0% |
| Return on invested capital | 25.71% | 8.36% | 9.37% | 0% |
| Profitability | 50% | 78% | 63% | 0% |
| Total debt ratio | 85.95% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | -2.52% | -11.36% | -57.43% | 0% |
| Dept financing | 25% | 24% | 17% | 25% |
| Current Ratio | 8.85% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 8.21% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 13% | 15% | 0% |
| Short-term ratios | RNAC | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -2.34% | 4.32% | 3.49% | 0% |
| Return on sales | 524.36% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 26% | 21% | 0% |
| Total debt ratio | 112.02% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | -5.03% | 0% | 0% | 0% |
| Dept financing | 25% | 18% | 38% | 0% |
| Current Ratio | 8.85% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 8.21% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 29% | 28% | 0% |
